Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 314

1.

Prostaglandin E₂ protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction.

Dackor RT, Cheng J, Voltz JW, Card JW, Ferguson CD, Garrett RC, Bradbury JA, DeGraff LM, Lih FB, Tomer KB, Flake GP, Travlos GS, Ramsey RW Jr, Edin ML, Morgan DL, Zeldin DC.

Am J Physiol Lung Cell Mol Physiol. 2011 Nov;301(5):L645-55. doi: 10.1152/ajplung.00176.2011.

2.

A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.

Zhu Y, Liu Y, Zhou W, Xiang R, Jiang L, Huang K, Xiao Y, Guo Z, Gao J.

Respir Res. 2010 Mar 20;11:34. doi: 10.1186/1465-9921-11-34.

3.

16,16-Dimethyl prostaglandin E2 efficacy on prevention and protection from bleomycin-induced lung injury and fibrosis.

Failla M, Genovese T, Mazzon E, Fruciano M, Fagone E, Gili E, Barera A, La Rosa C, Conte E, Crimi N, Cuzzocrea S, Vancheri C.

Am J Respir Cell Mol Biol. 2009 Jul;41(1):50-8. doi: 10.1165/rcmb.2007-0438OC.

PMID:
19059888
4.

Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis.

Redente EF, Jacobsen KM, Solomon JJ, Lara AR, Faubel S, Keith RC, Henson PM, Downey GP, Riches DW.

Am J Physiol Lung Cell Mol Physiol. 2011 Oct;301(4):L510-8. doi: 10.1152/ajplung.00122.2011.

5.

Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice.

Cai Y, Kimura S.

PLoS One. 2015 Nov 11;10(11):e0142497. doi: 10.1371/journal.pone.0142497.

6.

Static and dynamic mechanics of the murine lung after intratracheal bleomycin.

Manali ED, Moschos C, Triantafillidou C, Kotanidou A, Psallidas I, Karabela SP, Roussos C, Papiris S, Armaganidis A, Stathopoulos GT, Maniatis NA.

BMC Pulm Med. 2011 May 31;11:33. doi: 10.1186/1471-2466-11-33.

7.

Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis.

De Langhe E, Cailotto F, De Vooght V, Aznar-Lopez C, Vanoirbeek JA, Luyten FP, Lories RJ.

Respir Res. 2015 Mar 15;16:38. doi: 10.1186/s12931-015-0202-x.

8.

Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.

Bernau K, Ngam C, Torr EE, Acton B, Kach J, Dulin NO, Sandbo N.

Respir Res. 2015 Mar 27;16:45. doi: 10.1186/s12931-015-0206-6.

9.

Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis.

Inomata M, Kamio K, Azuma A, Matsuda K, Kokuho N, Miura Y, Hayashi H, Nei T, Fujita K, Saito Y, Gemma A.

Respir Res. 2014 Feb 8;15:16. doi: 10.1186/1465-9921-15-16.

10.

Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.

Gou S, Zhu T, Wang W, Xiao M, Wang XC, Chen ZH.

Int Immunopharmacol. 2014 Oct;22(2):498-504. doi: 10.1016/j.intimp.2014.07.010.

PMID:
25111852
11.

Airway remodeling in murine asthma correlates with a defect in PGE2 synthesis by lung fibroblasts.

Stumm CL, Wettlaufer SH, Jancar S, Peters-Golden M.

Am J Physiol Lung Cell Mol Physiol. 2011 Nov;301(5):L636-44. doi: 10.1152/ajplung.00158.2011.

12.

Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice.

Udalov S, Dumitrascu R, Pullamsetti SS, Al-tamari HM, Weissmann N, Ghofrani HA, Guenther A, Voswinckel R, Seeger W, Grimminger F, Schermuly RT.

BMC Pulm Med. 2010 May 5;10:26. doi: 10.1186/1471-2466-10-26.

13.

The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis.

Kulkarni AA, Thatcher TH, Hsiao HM, Olsen KC, Kottmann RM, Morrissette J, Wright TW, Phipps RP, Sime PJ.

PLoS One. 2013 May 31;8(5):e63798. doi: 10.1371/journal.pone.0063798.

14.
16.

Effects of IS-741, a synthetic anti-inflammatory agent, on bleomycin-induced lung injury in mice.

Shimaoka Y, Tajima S, Fujimori F, Yamabayashi C, Moriyama H, Terada M, Takada T, Suzuki E, Bando M, Sugiyama Y, Narita I.

Lung. 2009 Sep-Oct;187(5):331-9. doi: 10.1007/s00408-009-9162-6.

PMID:
19672658
17.

Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis.

Molina-Molina M, Serrano-Mollar A, Bulbena O, Fernandez-Zabalegui L, Closa D, Marin-Arguedas A, Torrego A, Mullol J, Picado C, Xaubet A.

Thorax. 2006 Jul;61(7):604-10.

18.

Ameliorative effect of mepenzolate bromide against pulmonary fibrosis.

Kurotsu S, Tanaka K, Niino T, Asano T, Sugizaki T, Azuma A, Suzuki H, Mizushima T.

J Pharmacol Exp Ther. 2014 Jul;350(1):79-88. doi: 10.1124/jpet.114.213009.

19.

Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice.

Murakami S, Nagaya N, Itoh T, Kataoka M, Iwase T, Horio T, Miyahara Y, Sakai Y, Kangawa K, Kimura H.

Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L59-65.

20.

Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.

Yasui H, Gabazza EC, Tamaki S, Kobayashi T, Hataji O, Yuda H, Shimizu S, Suzuki K, Adachi Y, Taguchi O.

Am J Respir Crit Care Med. 2001 Jun;163(7):1660-8.

PMID:
11401891
Items per page

Supplemental Content

Support Center